|
Figure 1 Independent Antibody Validation (IAV) via Protein Expression Profile in Human Cell LinesLoading: 15 &956,g of lysates per lane.Antibodies: Caspase 9, 2071 (1 &956,g/mL), Caspase 9, 2073 (1 &956,g/mL) and beta-actin (1.5 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. |
|
Figure 2 Western Blot Validation in Human Cell LinesLoading: 15 &956,g of lysates per lane.Antibodies: Caspase 9, 2071 (1 &956,g/mL)), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. |
|
Figure 3 Western Blot Validation in Human HeartLoading: 15 &956,g of lysates per lane.Antibodies: Caspase 9, 2071, 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: 1 &956,g/mLLane 2: 2 &956,g/mLLane 3: 4 &956,g/mL |
|
Figure 4 Western Blot Validation in HeLa Cell LysateLoading: 15 &956,g of lysates per lane.Antibodies: Caspase 9, 2071 (Lane 1: 0.5 &956,g/mL, Lane 2: 1 &956,g/mL and Lane 3: 2 &956,g/mL) , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. |
|
Figure 5 Western Blot Validation in Mouse Spleen TissueLoading: 15 &956,g of lysates per lane.Antibodies: Caspase 9, 2071 (Lane 1: 0.5 &956,g/mL, Lane 2: 1 &956,g/mL and Lane 3: 2 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: 0.5 &956,g/mLLane 2: 1 &956,g/mL and Lane 3: 2 &956,g/mL |
|
Figure 6 Western Blot Validation in Rat Spleen TissueLoading: 15 &956,g of lysates per lane.Antibodies: Caspase 9, 2071 (Lane 1: 0.5 &956,g/mL, Lane 2: 1 &956,g/mL and Lane 3: 2 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. |